Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...
A taurine-derived metabolite may hold the key to regulating food intake and body weight, potentially inspiring a new class of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback